Canopy Growth (TSE:WEED – Get Free Report) had its price target lowered by stock analysts at Canaccord Genuity Group from C$2.50 to C$1.50 in a research report issued on Monday,BayStreet.CA reports. The firm currently has a “sell” rating on the stock. Canaccord Genuity Group’s price objective points to a potential downside of 42.31% from the company’s previous close.
Separately, ATB Capital downgraded Canopy Growth from a “sector perform” rating to an “underperform” rating and dropped their target price for the stock from C$6.00 to C$4.00 in a report on Tuesday, December 17th. Four research analysts have rated the stock with a sell rating and one has issued a hold rating to the company. According to MarketBeat, the company currently has an average rating of “Reduce” and a consensus price target of C$5.40.
Canopy Growth Trading Down 8.1 %
About Canopy Growth
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names.
Featured Articles
- Five stocks we like better than Canopy Growth
- Market Cap Calculator: How to Calculate Market Cap
- META Stock: Insider Selling Ramps Up—What It Means for Investors
- The Risks of Owning Bonds
- 3 Chip Stocks Still Trading 50% Below Their 52-Week Highs
- High Dividend REITs: Are They an Ideal Way to Diversify?
- U.S. Steel: Will Trump-Backed Nippon Investment Drive Upside?
Receive News & Ratings for Canopy Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth and related companies with MarketBeat.com's FREE daily email newsletter.